NCT02841722View on ClinicalTrials.gov

Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin

NACompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

December 3, 2015

Primary Completion Date

December 3, 2015

Study Completion Date

January 10, 2020

Conditions
Breast Cancer
Interventions
PROCEDURE

ERIBULIN + G-CSF (Granulocyte-Colony Stimulating Factor)

8 additional blood samples

Trial Locations (1)

21079

CGFL, Dijon

All Listed Sponsors
lead

Centre Georges Francois Leclerc

OTHER

NCT02841722 - Evaluation and Modeling of the G-CSF Effect on the Evolution of Neutrophils During Chemotherapy Based on Eribulin | Biotech Hunter | Biotech Hunter